Treatments
Programme
Results
Experts
Resources
menu-close
WHAT WE TREAT
Weight loss
Weight loss
icon
Menopause
Menopause
icon
ACCOUNT
Log in
icon
OVERVIEW
Weight loss overview
Weight loss overview
icon
TREATMENTS
Explore all options
Explore all options
icon
Mounjaro
Mounjaro
Lose up to 23% body weight
icon
Wegovy
Wegovy
Lose up to 21% body weight
icon
Saxenda
Saxenda
Lose up to 10% body weight
icon
Orlos
Orlos
Lose up to 8% body weight
icon
PROGRAMME
How it works
How it works
icon
Coaching
Coaching
icon
App
App
icon
ABOUT
Results
icon
Experts
icon
RESOURCES
Guides & tips
icon
ACCOUNT
Log in
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
OUR CLINIC
Menopause overview
Menopause overview
icon
Pricing
icon
Clinicians
icon
TREATMENT PLANS
Hormone replacement therapy
icon
Testosterone treatment
icon
Cognitive behavioural therapy
icon
Vaginal treatments
icon
BLOOD TESTS
Women's midlife (MOT) blood test
icon
Monitor HRT blood test
icon
Start testosterone blood test
icon
WHAT WE TREAT
Skincare
New
icon
Perimenopause
icon
Menopause
icon
Sexual health
icon
Weight management
icon
LEARN
Guides
icon
Treatments
icon
ACCOUNT
Log in
icon
SUPPORT
FAQ
icon
Home/Guides & Tips/Medications/

Retatrutide dosage guide

Retatrutide dosage guide for weight loss

Retatrutide, a weekly weight loss injection, isn’t approved yet, but here’s what we know right now about the dosing schedule for this experimental treatment.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconUpdated 9th July 2025
Research-Based Guide
Table of contents
  • What is retatrutide?
  • Retatrutide dosing schedule
  • Why do I need to follow a reta...
  • What is the retatrutide mainte...
  • Your weight loss journey

Going by the clinical trial results we have so far, retatrutide may be the most effective weight loss medicine yet. After 48 weeks on retatrutide, people lost up to 24.2% of their body weight. On Mounjaro, the estimated average weight loss at 48 weeks is around 20.5%, based on data from a 72-week trial (since the studies had different designs and sample sizes, it's not possible to compare them like-for-like.)

Unlike Mounjaro though, retatrutide is yet to be approved and is still undergoing clinical trials. We’re still learning about how it affects the body—and we don’t know what doses it will be available in.

This last point is important. Dosing schedules are carefully chosen to ensure that the medicine is effective without causing unmanageable side effects. Clinical research is ongoing, but here’s what we know so far about retatrutide dosing for weight loss.

What is retatrutide?

Retatrutide is a new weekly weight loss injection that’s in development. Like Saxenda, Wegovy and Mounjaro, it makes you feel full so you eat less.

Though it works in a unique way. Saxenda and Wegovy—which use the active ingredients liraglutide and semaglutide, respectively—act like the natural hunger hormone GLP-1, while Mounjaro (tirzepatide) mimics the behaviour of GLP-1 as well as another hormone, GIP.

But retatrutide brings on the effects of three hormones: GLP-1, GIP, and GCG (aka glucagon). This triple effect suggests that it’s the most potent medicine of the bunch. Though we’re yet to see any research comparing it to currently available medicines head-to-head.

Still, if you're curious how these medications differ, check out our guide to retatrutide, tirzepatide, and semaglutide.

FYI: retatrutide is also being studied as a type 2 diabetes treatment.

Retatrutide dosing schedule

There’s no official schedule just yet—which means that we can’t give you a retatrutide dosage chart (sorry). But per clinical research, it looks like you would start retatrutide on a lower dose and gradually be moved up, just like with other weight loss injections.

Retatrutide dosage facts (so far)

  • Starting dose: 1mg or 2mg weekly (based on phase II trials)
  • Dose escalation: Increased every 4 weeks
  • Maximum dose: Up to 12mg weekly in trials
  • Maintenance dose: Varies by individual (4mg to 12mg in studies)

In a phase II trial, people were put in groups and assigned to different doses. A total of five retatrutide weekly doses were used in the study: 1mg, 2mg, 4mg, 8mg and 12mg.

For those who were due to receive retatrutide doses of 4mg or higher, they started on a lower strength and were gradually dialled up every four weeks, for up to 12 weeks. Most people started on 1mg or 2mg.

Why do I need to follow a retatrutide dosing schedule?

If you were new to running, would you attempt to run a marathon right away? Of course not. You would need to train your body by gradually running longer distances, until you were ready to tackle 26.2 miles.

It’s the same principle with retatrutide. You start on a lower dose so your body can adjust to the medicine—and then handle higher strengths down the line. This helps to reduce your risk of side effects.

What is the retatrutide maintenance dose?

We can’t say just yet. Because clinical research is still going on, we don’t know which doses of retatrutide will be available—let alone which would be the typical weight loss maintenance dose.

But in the phase II trial we mentioned earlier, some people were on a 12mg as the maximum dose.

The maximum tolerated dose is the strength of a medicine where it’s working like it’s supposed to without causing troublesome side effects. And because people can respond differently to a medicine, that dose might vary from person to person. Your provider will confirm what your maintenance dose is.

Your weight loss journey

Retatrutide isn’t due to hit the UK market until at least mid-2026. Yet there’s a bunch of other weight loss medications available right now that could help you reach your goals.

Don't wait to hit your health goals
Retatrutide isn’t available yet, but Wegovy and Mounjaro are already helping people lose weight. Start your journey today with proven treatments and support that sticks.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100k customers across the UK

You can get them posted to you each month when you sign up for our weight loss programme. Our dedicated team of clinicians and coaches will also work with you to transform your lifestyle—while cheering you on all the way.

Take our short quiz to find out if you’re eligible. We’ll review your results and come back to you within minutes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

FAQs about retatrutide dosage

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Aronne, Louis J et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMAscribble-underline vol. 331,1 (2024): 38-48. doi:10.1001/jama.2023.24945Aronne, Louis J, et al. “Continued Treatment With Tirzepatide For Maintenance Of Weight Reduction In Adults With Obesity: The SURMOUNT-4 Randomised Clinical Trial.” JAMAscribble-underline, vol. 331, no. 1, 2024:38-48. https://jamanetwork.com/journals/jama/fullarticle/2812936.

icon²

Doggrell, Sheila A. “Retatrutide Showing Promise In Obesity (And Type 2 Diabetes).” Expert Opinion on Investigational Drugsscribble-underline, vol. 32, issue 11, 2023:997-1001 https://www.tandfonline.com/doi/10.1080/13543784.2023.2283020.

icon³

Jastreboff, Ania M., et al. “Triple-hormone-receptor Agonist Retatrutide For Obesity—A Phase 2 Trial.” The New England Journal of Medicinescribble-underline, vol. 389, no. 6, 2023:514-526 https://www.nejm.org/doi/full/10.1056/NEJMoa2301972.

icon⁴

Naeem, Muhammad, et al. “Unleashing The Power Of Retatrutide: A Possible Triumph Over Obesity And Overweight: A Correspondence.” Health Science Reportsscribble-underline, vol. 7, no. 2, 2024:e1864 https://pmc.ncbi.nlm.nih.gov/articles/PMC10844714/.

icon⁵

Pasqualotto, Eric, et al. “Effects of Once-weekly Subcutaneous Retatrutide On Weight And Metabolic Markers: A Systematic Review And Meta-analysis of Randomized Controlled Trials.” Metabolism Openscribble-underline, vol. 24, 2024:100321 https://www.sciencedirect.com/science/article/pii/S2589936824000537?via%3Dihub.

Take the first step towards weight loss that lasts.

card-image
Medication
Ozempic side effects: Is it safe?
Like all medicines, Ozempic can cause side effects, though they’re mild and manageable for most people. Here’s what you need to know.
card-image
Medication
Mounjaro and breast cancer
New research in mice suggests Mounjaro could slow breast cancer growth. But could this effect translate to humans?
card-image
Medication
Trump calls Ozempic a “fat pill”
The comment has raised questions about what Ozempic actually is, whether it’s a pill or an injection, and how well it really works for weight loss.
Have a question?
phone icon
020 3912 9885Monday - Friday 9am - 5pm
support icon
help@joinvoy.comWe aim to reply in 24hrs
email icon
press@joinvoy.comPress & media inquiries
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999.

Programme

  • How it works
  • Treatments
  • Coaching
  • The Voy App

Voy

  • Medical experts
  • Results

Legal

  • Privacy policy
  • Terms & Conditions
  • Terms of Sale
  • Complaints

Get help

  • Help Centre (FAQ)
facebooktwitterinstagram
Copyright 2025 Voy. All rights reserved.
Pharmacies: Manual PharmacySuperintendent Pharmacist: Vinisha KandaGPhC Registration: 2203475
registered pharmacycqc ratingcpd member